A new vaccine that uses the protein PCSK9 has proven to lower bad cholesterol and even treat heart disease. When in combination to statins, the vaccine was proven to bring bad cholesterol to an even deeper drop.
According to the drug’s UPI report, the treatment was administered to both macaque monkeys and mice. The treatment is still in experimental change and an upgrade to human testing is not yet scheduled, but these promising developments could change the lives of millions of people who suffer of increased bad cholesterol.
The FDA recently approved two drugs recently that target this protein, but this is for patients with a very specific high bad cholesterol condition that is tied to genetics. These drugs are also extremely expensive, ranging between $7,000-$12,000 annually. The new vaccine has a stark difference in price. The results of these vaccines are striking and can bring a new treatment to people with high bad cholesterol with minimized side effects.
This new set of medications could target a large group of people of varying ages and could even help treat those with predisposition to high bad cholesterol, and hopefully human testing will bring good results and this drug can be on the market soon.
